Radionetics Oncology
Pharmaceuticals, San Diego, California, United States, 11-50 Employees
Who is RADIONETICS ONCOLOGY
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company...
Read More
-
Headquarters: San Diego, California, United States
-
Date Founded: 2021
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from RADIONETICS ONCOLOGY
Radionetics Oncology Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Radionetics Oncology
Answer: Radionetics Oncology's headquarters are located at San Diego, California, United States
Answer: Radionetics Oncology's official website is https://radionetics.com
Answer: Radionetics Oncology's revenue is $1 Million to $5 Million
Answer: Radionetics Oncology's SIC: 2834
Answer: Radionetics Oncology's NAICS: 325412
Answer: Radionetics Oncology has 11-50 employees
Answer: Radionetics Oncology is in Pharmaceuticals
Answer: Radionetics Oncology contact info: Phone number: Website: https://radionetics.com
Answer: Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The companys platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month